PMV PharmaceuticalsPMVP

那斯達克 · USD
1.19
+0.04
(+3.48%)
收盤 06/27 03:57 (UTC+8)
06/27 03:57 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
2023/Q4
營業收入淨額
-
-
-
-
-
-
-
-
-
-
營業成本
----------
營業毛利
-
-
-
-
-
-
-
-
-
-
營業費用
19,01919,24222,52322,87721,56425,16821,88920,17018,22118,902
研發費用
15,33015,82718,20918,40017,44113,76716,94714,62713,18613,382
推銷及管理費用
3,6893,4154,3144,4774,12311,4014,9425,5435,0355,520
非經常性項目費用
----------
其他營業費用
----------
營業利益
-19,019
-19,242
-22,523
-22,877
-21,564
-25,168
-21,889
-20,170
-18,221
-18,902
其他收入及費用
9811,2311,4571,6731,9312,1682,7362,7842,9513,145
利息費用
----------
稅前純益
-18,038
-18,011
-21,066
-21,204
-19,633
-23,000
-19,153
-17,386
-15,270
-15,757
所得稅
-26-76-2,197-73-16,173--1
稅後純益
-18,038
-18,037
-21,059
-21,210
-17,436
-23,000
-19,226
-1,213
-15,270
-15,756
基本每股稅後盈餘(元)
-0.34-0.33-0.40-0.41-0.34-0.45-0.37-0.02-0.30-
稀釋每股稅後盈餘(元)
-0.34-0.34-0.40-0.41-0.34-0.45-0.37-0.02-0.30-0.31
基本平均股數(千股)
53331.0053211.0052993.0052010.0051952.0051818.0051574.0051478.0051445.00-
稀釋平均股數(千股)
53331.0053211.0052993.0052010.0051952.0051818.0051574.0051478.0051445.00-
還原基本每股稅後盈餘(元)
-0.34-0.33-0.40-0.41-0.34-0.45-0.37-0.02-0.30-
還原稀釋每股稅後盈餘(元)
-0.34-0.34-0.40-0.41-0.34-0.45-0.37-0.02-0.30-0.31
還原基本平均股數(千股)
53,33153,21152,99352,01051,95251,81851,57451,47851,445-
還原稀釋平均股數(千股)
53,33153,21152,99352,01051,95251,81851,57451,47851,445-
EBITDA(千元)
-18,389-18,491-21,729-21,896-20,436-24,093-20,017-18,390-16,536-17,273

大家都在看

HOT